For those who can work at all — around 8 in 10, one study found — accommodations are often what makes it possible. The costs ...
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.Britta Shoot ...
In September, BioVie reported phase 2 trial results for the novel drug bezisterim, which may improve Long COVID symptoms such as fatigue and post-exertional malaise (PEM) as well as neurological ...
This summer’s COVID-19 wave is still lingering into the fall, as much of the country reports ongoing moderate to high disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results